Shlomo Shinnar Selected Research

fosphenytoin (Cerebyx)

1/2022	Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status Epilepticus.
1/2021	Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
11/2020	Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
1/2020	The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus.
12/2019	Lessons from the Established Status Epilepticus Treatment Trial.
11/2019	Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shlomo Shinnar Research Topics

Disease

23	Seizures (Absence Seizure) 01/2022 - 01/2002
15	Epilepsy (Aura) 01/2018 - 01/2002
13	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 10/2011
6	Absence Epilepsy (Childhood Absence Epilepsy) 10/2017 - 03/2010
6	Infantile Spasms (West Syndrome) 01/2014 - 03/2004
4	Epileptic Syndromes 10/2017 - 01/2005
3	Anemia 01/2020 - 01/2006
3	Hypertension (High Blood Pressure) 01/2020 - 01/2006
2	Multiple Sclerosis 01/2018 - 01/2016
2	Atrophy 01/2018 - 01/2016
2	Febrile Seizures (Febrile Seizure) 01/2017 - 01/2002
2	Cognitive Dysfunction 01/2017 - 01/2017
2	Temporal Lobe Epilepsy 01/2017 - 10/2011
2	Drug Resistant Epilepsy 01/2009 - 10/2006
2	Idiopathic Generalized Epilepsy 03/2006 - 01/2005
1	Hypotension (Low Blood Pressure) 11/2019
1	Disease Progression 06/2018
1	Headache (Headaches) 01/2018
1	Chronic Progressive Multiple Sclerosis 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 11/2017
1	Overweight 04/2016
1	Obesity 04/2016
1	Respiratory Insufficiency (Respiratory Failure) 01/2016
1	Rett Syndrome (Rett's Disorder) 01/2016
1	Developmental Disabilities (Developmental Disability) 03/2014
1	Autistic Disorder (Autism) 03/2014
1	Spasm (Spasms) 01/2014
1	Viremia 09/2012
1	Proteinuria 08/2011
1	Kidney Diseases (Kidney Disease) 02/2010
1	Brain Neoplasms (Brain Tumor) 09/2009
1	Malformations of Cortical Development 01/2008
1	Lennox Gastaut Syndrome 10/2006
1	Juvenile Myoclonic Epilepsy 03/2006
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2006

Drug/Important Bio-Agent (IBA)

14	Anticonvulsants (Antiepileptic Drugs)IBA 11/2019 - 01/2002
10	BenzodiazepinesIBA 01/2022 - 05/2007
10	Pharmaceutical PreparationsIBA 01/2021 - 07/2006
9	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 03/2010
6	fosphenytoin (Cerebyx)FDA LinkGeneric 01/2022 - 11/2019
6	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 11/2019
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2011
4	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2014 - 03/2004
3	Ethosuximide (Zarontin)FDA LinkGeneric 10/2013 - 03/2010
3	Lamotrigine (Lamictal)FDA LinkGeneric 10/2013 - 03/2010
2	Retinaldehyde (Retinal)IBA 01/2018 - 01/2016
2	ibudilastIBA 01/2018 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 11/2017 - 01/2017
2	Diazepam (Valium)FDA LinkGeneric 01/2016 - 09/2005
2	Prednisolone (Predate)FDA LinkGeneric 01/2014 - 11/2005
2	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 09/2012
2	Immunoglobulin E (IgE)IBA 03/2006 - 01/2005
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2021
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2020
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Biological ProductsIBA 06/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Cyclic NucleotidesIBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2017
1	CytokinesIBA 01/2017
1	CarbonIBA 01/2017
1	LigandsIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2017
1	CarbohydratesIBA 04/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Lorazepam (Ativan)FDA LinkGeneric 01/2016
1	Midazolam (Versed)FDA LinkGeneric 01/2016
1	Glatiramer Acetate (Copaxone)FDA Link 01/2016
1	Aligeron (AS 2)IBA 01/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2012
1	RNA (Ribonucleic Acid)IBA 09/2012
1	NeuropeptidesIBA 11/2011
1	Therapeutic UsesIBA 11/2011
1	CreatinineIBA 08/2011
1	Proteins (Proteins, Gene)FDA Link 08/2011
1	Iohexol (Omnipaque)FDA Link 02/2010
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2009
1	Felbamate (Felbatol)FDA Link 10/2006
1	EnzymesIBA 01/2005
1	gamma-Aminobutyric Acid (GABA)IBA 01/2005
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 03/2004
1	Prednisone (Sone)FDA LinkGeneric 03/2004

Therapy/Procedure

10	Therapeutics 11/2020 - 01/2002
1	Aftercare (After-Treatment) 01/2022
1	Intravenous Administration 01/2021
1	Emergency Treatment 03/2014
1	Complementary Therapies (Alternative Medicine) 03/2014
1	Continuity of Patient Care 10/2010
1	Hemispherectomy 01/2008
1	Kidney Transplantation 01/2006
1	Transplantation 01/2006